Structure of Human Type II 5 Alpha-Reductase Gene

    September 1992 in “ Endocrinology
    Fernand Labrie
    Image of study
    TLDR The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.
    The document from 1992 detailed the isolation and characterization of the human type II 5α-reductase gene, which plays a role in conditions like male pseudohermaphroditism, prostate cancer, and benign prostatic hyperplasia. The gene was found to have five exons and four introns, with exon sizes ranging from 102 to 1695 base pairs and intron sizes exceeding 2.0 kilobases. There was a notable homology of 43.8% to 64.1% between the exons of this gene and those of the type I 5α-reductase gene. A transcription start site was located 71 nucleotides before the ATG initiating codon, and a single nucleotide difference was identified in the coding region, altering an amino acid from valine to leucine. Southern blot analysis confirmed the gene's structure and its low homology with other related genes. The study also provided insights into the gene's role in DHT formation and action in androgen target tissues, which could aid in the analysis of 5α-reductase deficiency and related endocrine disorders.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Low cortisol it is due the fin

      in Finasteride/Dutasteride  7 upvotes 2 weeks ago
      The user has been taking 1mg finasteride daily for a year with no improvement in hair loss and reports low cortisol levels, sleep issues, and anxiety changes. The conversation includes discussions on the potential effects of finasteride on cortisol and neurosteroids, with suggestions to consult a doctor and consider other factors.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 11 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community risks with finasteride and dutasteride

      in Research/Science  139 upvotes 1 month ago
      Finasteride and dutasteride have potential risks, including post-finasteride syndrome, but are commonly used for hair loss. RU58841, minoxidil, and needling are suggested as alternatives, though all treatments carry risks.

    Similar Research

    6 / 1000+ results